Ligand-Gated Ion Channel Database

Haptoglobin (Hpt/HP) ELISA Kit — Research-Grade Quantification Guide

• Nicolas
• October 9, 2025
• 0

Background on Haptoglobin (HP/Hpt)

Haptoglobin (gene HP) is a plasma glycoprotein that binds free hemoglobin in circulation, forming Hpt-Hb complexes that are subsequently cleared. Gene-level information, protein isoforms, and polymorphisms are documented at [NCBI Gene: HP] (cite—no browsing; direct resource for context):

• NCBI Gene – HP

• MedlinePlus Genetics – HP overview

• NCBI Protein (HP entries)

• dbSNP – HP variants

• UCSC Genome Browser (HP locus)

For literature scanning and mechanistic studies, see:

• PubMed – HP research

• PubMed Central (Open Access)

RUO note: The kit and workflow below are for research use only and not for diagnostic procedures. Refer to RUO labeling principles at FDA – RUO/IUO Labeling and rigor guidance at NIH Rigor & Reproducibility.

Research Applications

• Quantitative monitoring of Hpt levels in serum, plasma, cell culture supernatants, and other validated matrices in preclinical or method-development contexts.

• Investigations of protein binding and complex formation with hemoglobin, guided by general assay design practices from the Assay Guidance Manual (NCBI Bookshelf).

• Inclusion in multi-analyte panels; use common data elements and metadata standards where appropriate (NLM CDE).

Assay Principle (Sandwich ELISA)

This sandwich ELISA uses a capture antibody pre-coated on 96-well microplates. Samples or standards are added; Hpt binds the capture antibody. After washing, an enzyme-conjugated detection antibody is added, forming a capture–analyte–detector sandwich. Following substrate addition (e.g., TMB), color development is measured at 450 nm with reference 570–650 nm where supported. Quantification is via a 4-parameter logistic (4PL) or 5PL standard curve. For general ELISA overviews and curve-fitting fundamentals:

• NIST e-Handbook of Statistical Methods (Modeling/Regression)

• Assay Guidance Manual – Data analysis, QC

Kit Components (Typical)

• 96-well microplate pre-coated with anti-Hpt capture antibody (strips)

• Hpt Calibrator/Standard, lyophilized (traceability documented; consider cross-referencing to reference materials where applicable, e.g., NIST SRM program)

• Detection antibody (enzyme-conjugated)

• Sample diluent / standard diluent

• Wash buffer (10× or 20×)

• Substrate (e.g., TMB), stop solution

• Plate sealers, detailed IFU (instructions for use)

Materials and Instruments (User-Supplied)

• Microplate reader capable of 450 nm

• Calibrated single/multi-channel pipettes; certified tips

• Centrifuge for sample clarification

• Deionized water (resistivity ≥18 MΩ·cm)

• Vortex mixer, plate shaker (optional, per IFU)

• Image analysis / curve-fit tools (e.g., ImageJ tools for processing: imagej.nih.gov; or software that supports 4PL/5PL)

Sample Type, Collection, and Storage (Research Context)

• Serum: Allow clotting; centrifuge; transfer supernatant.

• Plasma: Use EDTA or heparin; centrifuge promptly.

• Cell culture supernatant: Clarify by centrifugation.

• Avoid repeated freeze-thaw cycles. Align with best practices for biospecimen handling:

  • NCI Best Practices for Biospecimen Resources

  • CDC – Specimen submission/handling overview

Document chain-of-custody, storage temperature, and sample age to support reproducibility (NIH Rigor).

Standard Curve and Calculation

For curve-fitting math, weighting (1/y²), residual analysis, and outlier handling, consult:

• NIST e-Handbook – Regression/Residuals

• Assay Guidance Manual – Curve fitting & QC

Analytical Performance (Research Validation)

Sensitivity (LoD/LoQ). Determine using blank replicates and low-level spikes.
Linearity of dilution. Dilute real samples (e.g., 1:2–1:16) and back-calculate %-recovery (acceptable research range often 80–120%).
Spike & recovery. Spike known Hpt into matrix; compute %-recovery to detect matrix effects.
Precision.

• Intra-assay (within-run): n≥20 replicates across at least 3 levels

• Inter-assay (between-run/day/operator): n≥20 across days
  Report %CV for both. See quality systems references:

• NIST – Measurement Quality & Metrology

• EPA – Quality Assurance Project Plans (QA/QC concepts)

Interference & Robustness Studies

Evaluate potential interferents relevant to plasma/serum assays:

• Hemolysis, lipemia, bilirubin, high total protein, heterophilic antibodies, and rheumatoid factor.

• Document acceptance criteria and impacts on recovery. For general lab standards/considerations:

  • CDC – Laboratory Quality/Standards (overview)

  • NIST – Reference Materials & Comparability

Plate Layout Strategy

• Allocate duplicate wells for each calibrator, QC, and unknown.

• Include blank and matrix control positions.

• Maintain symmetry across the plate to minimize edge effects (document incubation uniformity).

• Record lot numbers for all reagents as per best practices (NCI Best Practices).

Data Integrity & Documentation

• Maintain full metadata (sample ID, matrix, dilution, freeze-thaw count, operator).

• Store raw data files, plate maps, and curve parameters in a compliant archive.

• For structured study registration and awareness of the broader research landscape (if applicable to design phases), see:

  • ClinicalTrials.gov (registry & transparency)

  • NIH Rigor & Reproducibility

Troubleshooting (Quick Reference)

• Low signal: Verify enzyme conjugate activity; confirm correct substrate and stop times.

• High background: Increase wash stringency; verify blocking and plate sealing.

• Poor linearity: Remake standard dilutions; check pipetting and mix thoroughly.

• Hook effect (very high Hpt): Perform additional sample dilution and re-read.

• Drift across plate: Ensure consistent incubation time and temperature; avoid stacked plates.

For general toolsets and image processing (gel images, colorimetric analysis screenshots for records), see:

• ImageJ – NIH

Example Research-Only Reporting Template

• Analyte: Haptoglobin (HP/Hpt)

• Matrix: Human serum (EDTA plasma also tested)

• Dynamic range (calibrators): e.g., 0.1–10 µg/mL (example; use kit IFU)

• Sensitivity: LoD/LoQ determined per 20 blanks (document stats per NIST Handbook)

• Precision: Intra-assay %CV ≤ X%; Inter-assay %CV ≤ Y%

• Spike-recovery: 90–110% across low/medium/high spikes

• Linearity: 85–115% across 1:2–1:16 dilutions

• Interference: No significant effect within tested ranges of hemoglobin, triglycerides, bilirubin (define mg/dL ranges in report)

Compliance, RUO Labeling, and Good Practices

• Mark “For Research Use Only” on all reports and labels; do not state diagnostic interpretation (see FDA RUO/IUO).

• Use documented SOPs compatible with quality frameworks such as USGS QA principles and general federal QA guidance (EPA QA).

• Adopt consistent metadata and definitions leveraging NLM MeSH – Haptoglobins.

SEO Enhancers (Non-promissory, Research-Focused)

Suggested H1: Haptoglobin (HP) ELISA Kit for Research — Sensitive, Robust Quantification
H2 ideas:

• Assay Principle and 4PL/5PL Calibration

• Research Validation: Precision, Linearity, Recovery

• Interference Testing and Matrix Effects

• Plate Layout, QC, and Data Integrity

• Troubleshooting: Low Signal, High Background, Hook Effect

Internal linking ideas (site-wide):

• Link to ELISA buffers & consumables category

• Link to microplate readers and calibration standards

• Link to research protocols and RUO statement page

Image alt-text suggestions:

• “Haptoglobin ELISA standard curve (4PL) — research data”

• “Hpt sandwich ELISA plate layout with calibrators and QCs”

• “Pipetting serial dilutions for HP standard curve (laboratory workflow)”